Dr. Federico Girardi, Orthopedic Spine Surgeon

Federico P. Girardi, MD
Orthopedic Surgery, Spine

Dr. Federico Girardi, Orthopedic Spine Surgeon

Federico P. Girardi, MD


Orthopedic Surgery, Spine
Dr. Federico Girardi, Orthopedic Spine Surgeon

Federico P. Girardi, MD


East River Professional Building
523 East 72nd Street
New York, NY 10021

Tel: 212.606.1559
East River Professional Building
523 East 72nd Street
New York, NY 10021

Tel: 212.606.1559

Dr. Federico P. Girardi specializes in the surgical treatment of different spinal disorders, including but not limited to: degenerative (disc herniation, degenerative disc disease, stenosis), deformity (scoliosis, kyphosis, flat-back), metabolic (osteoporosis), fractures, and tumors of the cervical, thoracic and lumbar spine.

He has done extensive clinical research involving the areas of minimally invasive surgery, clinical outcomes of different surgical procedures, and imaging modalities of the spine. Dr. Girardi is currently involved in the STRIVE study, a worldwide clinical trial to see if an investigational vaccine given before spinal surgery can prevent infection. He is also interested in the basic science aspects of bone, disc and nerve tissue regeneration as well as the investigation of alternatives to spinal fusion for the treatment of degenerative disc disease.

Back in the Game Patient Stories

Appointments

Attending Orthopaedic Surgeon, Hospital for Special Surgery
Professor of Orthopaedic Surgery, Weill Cornell Medical College
Associate Scientist, Research Division, Hospital for Special Surgery

Specialty

Specialized Centers

Special Expertise

Lumbar, Thoracic, and Cervical Spinal Disorders
Degenerative Conditions: Disc herniations, Degenerative Disc Disease, Spinal Stenosis, Spondylolisthesis
Spinal Deformities (Scoliosis, Kyphosis)
Minimally Invasive Surgery
Spine Non-fusion Surgery

Awards

Team Science Award, Translational Science (ACRT, AFMR, APOR, SCTS) Washington, DC, 2012
Best Resident Research Study, 1993

Affiliations

Member, American Medical Association
Member, Hospital for Special Surgery Alumni Association
Member, Medical Society of the State of New York
Member, New York County Medical Society
Member, Scoliosis Association
Member, Argentine Association of Orthopaedics and Traumatology (AAOT)
Member Nucleus Arthroplasty Society (SONA)
Member, Society for the Lateral Access Surgery (SOLAS)
Member, North American Spine Society (NASS)
Member, Scoliosis Research Society (SRS)
Member, European Spine Society (ESS)
Member, International Society for the Study of the Lumbar Spine (ISSLS)
Member, Spine Arthroplasty Society (SAS)

Languages

Spanish

Insurance Information

Aetna
Blue Cross HMO POS
Blue Cross PPO
Blue Cross Pathway
Blue Cross Pathway Enhanced
Connecticare
HIP
Medicare
Oxford
Oxford Medicare
United Healthcare

Please do not hesitate to contact our office if you have questions regarding your insurance coverage. You may still have coverage subject to the availability of 'out-of-network' benefits.

Education

MD, Universidad Nacional de Rosario, Rosario,  Argentina

Residency

Hospital de Clinicas “Jose de San Martin” Buenos Aires University, Orthopedic Surgery and Traumatology, Buenos Aires, Argentina

Fellowship

Hospital for Special Surgery, Spine & Scoliosis Surgery, New York

Certification

American Board of Orthopaedic Surgery

State Licensure

New York, Connecticut

Editorial Appointments

2000, Present, Editorial Reviewer, SPINE Journal, Editor-in-Chief Dr. James N. Weinstein 
2001, Editorial Reviewer, Journal of Orthopaedic Research, Editor-in-Chief Timothy M. Wright, PhD
2002, Guest Editor, The Orthopedic Clinics of North America, Advances in Spine Surgery
2003, Editorial Reviewer, Journal Clinical Drug Investigation
2004, Editorial Reviewer, Clinical Orthopedics and Related Research
2005, Editorial Reviewer, British Medical Journal
2004, Editorial Reviewer, European Spine Journal
2007, Deputy Editor, Spine Arthroplasty Society Journal
2008 - Present, Contributing Author, Interactive Educational Program (IEP)  
2009 - Present, Editorial Review Board Minimally Invasive Surgery
2010 - 2014, Editorial Board, World Journal of Orthopaedics
2011, Review Panel, Interactive Educational Program (IEP) Awards
2012, Deputy Editor, International Journal of Spine Surgery

Selected Publications

Lebl DR, Sama AA, Pumberger M, Kotwal S, Cammisa FP Jr, Girardi FP: “Reamed Transacral Interbody Fusion for L5-S1 Pseudarthrosis: A Novel Salvage Technique in 10 Patients” J Spinal Disord Tech. 2012 Jan 17.

Kepler CK, Sharma AK, Huang RC, Meredith DS, Girardi FP, Cammisa FP Jr, Sama AA: ”Indirect Foraminal Decompression after Lateral Transpsoas Interbody Fusion” Journal of Neurosurgery: Spine 2012 Jan 27.  

Taher F, Essig D, Lebl DR, Hughes AP, Sama AA, Cammisa FP, Girardi FP:  “Lumbar Degenerative Disc Disease – Current and Future Concepts of Diagnosis and Management" Advances in Orthopedics 2012;2012:970752. Epub 2012 Apr 2.

Kepler CK, Huang RC, Sharma AK, Meredith DS, Metitiri O, Sama AA, Girardi FP, Cammisa FP:  “Factors Influencing Segmental Lumbar Lordosis After Lateral Transpsoas Interbody Fusion”  Orthop Surg. 2012 May;4(2):71-5.

Pawar A, Essig D, Girardi FP, Cammisa FP Jr, Fantini G, Hughes AP. Lateral Lumbar Interbody Fusion. Journal of the American Academy of Orthopaedic Surgery.  In Press.

 

For more publications, please see the PubMed listing.

Professional Education by Dr. Girardi on HSS.edu

Research Description

Current Research Includes:
Tissue Regeneration
Disc Replacement (Disc Prosthesis) and non-fusion technologies
Imaging of the spine
Clinical Outcomes
Minimally Invasive Surgery
Image Guided Stereotactic Surgery

STRIVE Study
HSS, along with medical centers around the country, in Europe, Japan, and Canada, is taking part in a study to evaluate the safety and efficacy of an investigational vaccine when administered to adults undergoing a spinal fusion surgical procedure. The research is part of the HSS commitment to quality by continually striving to improve long-term outcomes.

The goal of the study is to investigate whether a single vaccination given 10-60 days before spinal surgery can prevent Staphylococcus aureus (staph) infections. Although rare, affecting only 1 to 3% of patients nationwide, an infection is always serious and any measure that could potentially prevent an infection could improve patient outcomes.

The safety and tolerability of the current investigational vaccine for Staphylococcus aureus have already been studied in healthy adult participants in four previous clinical trials.

The next step is to study the safety and efficacy of this investigational vaccine in patients planning a spinal fusion surgical procedure.

The study is open to adults 18 to 85 years of age meeting certain criteria. Please consult your physician for more information. Learn more

Clinical Trials